TNF Pharmaceuticals shareholders approve 15x increase in authorized common stock to 250M shares

Q/C TECHNOLOGIES, INC.

Authorized common shares increased from 16,666,666 to 250,000,000; amendment filed July 25, 2024.
Shareholders also approved issuance of shares underlying Series F-1 and G Preferred and warrants for Nasdaq Rule 5635 compliance.
Share Increase Proposal vote: 819,760 for, 73,259 against, 12,851 abstain.
Ratification of Morison Cogen as independent auditor for FY2024 passed with 1,536,758 votes for.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.